How I do it: Aquablation in very large prostates (> 150 mL)

Area of Science:

• Urology
• Minimally Invasive Surgery

Background:

• Aquablation therapy is a minimally invasive treatment for benign prostatic hyperplasia (BPH).
• Previous studies focused on prostates up to 150 mL.
• New guidelines categorize prostates > 150 mL as 'very large'.

Purpose of the Study:

• To explore the application and efficacy of Aquablation therapy in very large prostates (> 150 mL).
• To provide guidance on utilizing Aquablation for this specific patient cohort.

Main Methods:

• Review of existing data and clinical experience with Aquablation therapy.
• Analysis of treatment outcomes in prostates exceeding 150 mL.

Main Results:

• Aquablation demonstrates feasibility and effectiveness in prostates > 150 mL.
• The therapy offers a viable surgical option for the 'very large' prostate category.

Conclusions:

• Aquablation therapy is a suitable treatment for very large prostates.
• This expands the utility of Aquablation for a broader range of BPH patients.